Clinical trials

  • EPCORITAMAB for B-cell non-Hodgkin lymphoma | Diffuse large B-cell lymphoma | Follicular lymphoma
  • SACITUZUMAB GOVITECAN for PD-L1-negative metastatic triple-negative breast cancer | PD-L1-positive metastatic triple-negative breast cancer
  • Budesonide for Chronic obstructive pulmonary disease (COPD)
  • EPCORITAMAB for B-cell lymphoma | Non-Hodgkin B-cell lymphoma
  • SACITUZUMAB GOVITECAN for Triple-negative breast cancer (metastatic, PD-L1 positive)
  • ASCORBIC ACID|UBIQUINOL for Mitochondrial disorders|Cerebellar ataxia
  • DOSTARLIMAB for Non-small cell lung cancer
  • DICLOFENAC SODIUM for Metastatic melanoma
  • Bomedemstat for Essential thrombocythemia
  • GUSELKUMAB for Ulcerative colitis
  • CAMIZESTRANT for Advanced breast cancer
  • GUSELKUMAB, GOLIMUMAB for Crohn's disease (moderately to severely active)